Equillium Inc (EQ)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track

Stock chart

Ticker: EQ Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-01-24	2025-01-23	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	10,000 -21.0% 0.65 USD 6,500	10,000 -21.0%	0.65	USD 6,500
2024-11-15	2024-11-14	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	10,000 -17.3% 0.70 USD 7,000	10,000 -17.3%	0.70	USD 7,000
2024-10-30	2024-10-28	PS Planned sale	Zedelmayer Christine Sr. Vice President and COO Officer	15,000 -10.0% 1.25 USD 18,750	15,000 -10.0%	1.25	USD 18,750
2024-10-29	2024-10-28	PS Planned sale	Tom Penny Principal Accounting Officer Officer	2,835 -30.3% 1.25 USD 3,544	2,835 -30.3%	1.25	USD 3,544
2024-10-29	2024-10-25	PS Planned sale	Tom Penny Principal Accounting Officer Officer	683 -6.8% 1.25 USD 854	683 -6.8%	1.25	USD 854
2024-09-27	2024-09-26	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	10,000 -14.8% 0.81 USD 8,100	10,000 -14.8%	0.81	USD 8,100
2024-09-17	2024-09-16	PS Planned sale	Tom Penny Principal Accounting Officer Officer	38,806 -79.4% 0.85 USD 32,985	38,806 -79.4%	0.85	USD 32,985
2024-07-18	2024-07-16	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	10,000 -12.9% 0.87 USD 8,700	10,000 -12.9%	0.87	USD 8,700
2022-08-30	2022-08-29	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	7,000 -8.3% 2.83 USD 19,810	7,000 -8.3%	2.83	USD 19,810
2022-06-06	2022-06-06	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	5,000 -5.6% 2.52 USD 12,600	5,000 -5.6%	2.52	USD 12,600
2022-04-05	2022-04-04	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	8,000 -8.2% 3.18 USD 25,440	8,000 -8.2%	3.18	USD 25,440
2021-12-03	2021-12-01	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	5,000 -4.9% 5.08 USD 25,402	5,000 -4.9%	5.08	USD 25,402
2021-11-17	2021-11-16	PS Planned sale	Zedelmayer Christine Sr. Vice President and COO Officer	7,350 -6.7% 5.49 USD 40,315	7,350 -6.7%	5.49	USD 40,315
2021-11-17	2021-11-16	PS Planned sale	Zedelmayer Christine Sr. Vice President and COO Officer	4,084 -4.1% 5.49 USD 22,401	4,084 -4.1%	5.49	USD 22,401
2021-10-07	2021-10-06	PS Planned sale	Connelly Stephen Chief Scientific Officer Executive Director	2,467 -0.2% 7.01 USD 17,288	2,467 -0.2%	7.01	USD 17,288
2021-10-07	2021-10-06	PS Planned sale	Connelly Stephen Chief Scientific Officer Executive Director	5,625 -0.6% 7.01 USD 39,418	5,625 -0.6%	7.01	USD 39,418
2021-09-29	2021-09-27	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	8,000 -7.2% 6.74 USD 53,924	8,000 -7.2%	6.74	USD 53,924
2021-06-09	2021-06-08	S Sale	Connelly Stephen Chief Scientific Officer Executive Director	10,495 -1.0% 7.18 USD 75,315	10,495 -1.0%	7.18	USD 75,315
2021-06-09	2021-06-07	S Sale	Connelly Stephen Chief Scientific Officer Executive Director	13,900 -1.4% 7.14 USD 99,264	13,900 -1.4%	7.14	USD 99,264
2021-06-09	2021-06-07	S Sale	Connelly Stephen Chief Scientific Officer Executive Director	8,490 -0.8% 7.08 USD 60,145	8,490 -0.8%	7.08	USD 60,145
2021-06-09	2021-06-04	S Sale	Connelly Stephen Chief Scientific Officer Executive Director	7,030 -0.7% 7.01 USD 49,245	7,030 -0.7%	7.01	USD 49,245
2021-06-09	2021-06-04	S Sale	Connelly Stephen Chief Scientific Officer Executive Director	6,509 -0.7% 7.01 USD 45,601	6,509 -0.7%	7.01	USD 45,601
2021-05-28	2021-05-26	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	5,000 -4.1% 6.50 USD 32,484	5,000 -4.1%	6.50	USD 32,484
2020-12-30	2020-12-28	PS Planned sale	Connelly Stephen Chief Scientific Officer Executive Director	25,000 -2.5% 4.52 USD 113,045	25,000 -2.5%	4.52	USD 113,045
2020-12-28	2020-12-23	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	8,000 -6.2% 4.74 USD 37,914	8,000 -6.2%	4.74	USD 37,914
2020-07-15	2020-07-13	PS Planned sale	Connelly Stephen Chief Scientific Officer Executive Director	250,000 -19.3% 8.13 USD 2,033,475	250,000 -19.3%	8.13	USD 2,033,475
2020-02-19	2020-02-18	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	5,000 -3.7% 5.03 USD 25,138	5,000 -3.7%	5.03	USD 25,138
2020-01-22	2020-01-21	PS Planned sale	Keyes Jason A Chief Financial Officer	5,000 -3.6% 4.41 USD 22,043	5,000 -3.6%	4.41	USD 22,043
2019-09-04	2019-09-03	PS Planned sale	Keyes Jason A Chief Financial Officer	5,000 -3.5% 3.60 USD 17,981	5,000 -3.5%	3.60	USD 17,981
2019-08-05	2019-08-01	PS Planned sale	Keyes Jason A Chief Financial Officer Officer	5,000 -3.4% 3.99 USD 19,941	5,000 -3.4%	3.99	USD 19,941

Equillium Inc (EQ)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by